Articles published by Cellectis Inc.
Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing
June 20, 2024
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
June 12, 2024
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
From Cellectis Inc.
Via GlobeNewswire
From Cellectis Inc.
Via GlobeNewswire
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
November 17, 2023
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
November 15, 2023
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
November 01, 2023
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
August 03, 2023
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 27, 2023
June 28, 2023
From Cellectis Inc.
Via GlobeNewswire
Tickers
CLLS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.